📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 Agonists. (2024)

First Author: Wang P

Attributed to: University of Oxford – Confidence in Concept 2019 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.3c00951

PubMed Identifier: 38146625

Publication URI: http://europepmc.org/abstract/MED/38146625

Type: Journal Article/Review

Volume: 67

Parent Publication: Journal of medicinal chemistry

Issue: 1

ISSN: 0022-2623